🇪🇺 Orencia in European Union

Orencia (abatacept) regulatory status in European Union.

Marketing authorisation

EMA

  • Application: EMEA/H/C/000701
  • Local brand name: Orencia
  • Status: approved

Orencia in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in European Union

Frequently asked questions

Is Orencia approved in European Union?

Yes. EMA has authorised it.

Who is the marketing authorisation holder for Orencia in European Union?

Bristol-Myers Squibb is the originator. The local marketing authorisation holder may differ — check the official source linked above.